Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Dec 09, 2024

SELL
$67.31 - $124.76 $2.78 Million - $5.15 Million
-41,245 Closed
0 $0
Q2 2022

Dec 09, 2024

BUY
$62.69 - $88.44 $100,304 - $141,504
1,600 Added 4.04%
41,245 $3.09 Million
Q1 2022

Dec 09, 2024

BUY
$63.15 - $90.42 $981,666 - $1.41 Million
15,545 Added 64.5%
39,645 $3.1 Million
Q2 2021

Dec 09, 2024

SELL
$69.38 - $86.75 $291,257 - $364,176
-4,198 Reduced 14.83%
24,100 $1.87 Million
Q1 2021

Dec 09, 2024

BUY
$72.25 - $168.95 $2.04 Million - $4.78 Million
28,298 New
28,298 $2.11 Million

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.7B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Swedbank Ab Portfolio

Follow Swedbank Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swedbank Ab, based on Form 13F filings with the SEC.

News

Stay updated on Swedbank Ab with notifications on news.